Global Topical Corticosteroids Market 2024-2028

Publisher TechNavio

Published Jul 25, 2024

Length 164 Pages

SKU # INF19384847

Description

Global Topical Corticosteroids Market 2024-2028

Global Topical Corticosteroids Market 2024-2028

The topical corticosteroids market is forecasted to grow by USD 1364.6 mn during 2023-2028, accelerating at a CAGR of 4.74% during the forecast period. The report on the topical corticosteroids market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advancements in drug delivery systems, growing aging population, and rising prevalence of skin disorders.

Technavio's topical corticosteroids market is segmented as below:

By End-user
Hospitals
Dermatology clinics
Pharmacies
Others
By Type
Prescription
OTC
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing adoption of generic drugs as one of the prime reasons driving the topical corticosteroids market growth during the next few years. Also, development of novel formulations and growing demand for natural and organic products will lead to sizable demand in the market.

The report on the topical corticosteroids market covers the following areas:

Topical corticosteroids market sizing
Topical corticosteroids market forecast
Topical corticosteroids market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading topical corticosteroids market vendors that include AbbVie Inc., Astellas Pharma Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer AG, Cipla Inc., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Galderma SA, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., LEO Pharma AS, Merck and Co. Inc., Novartis AG, Perrigo Co. Plc, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the topical corticosteroids market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Topical Corticosteroids Market 2018 - 2022; Historic Market Size - Data Table on Global Topical Corticosteroids Market 2018 - 2022 ($ million); 4.2 End-user segment analysis 2018 - 2022; Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.3 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Chart on End-user - Market share 2023-2028 (%); Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 6.3 Hospitals - Market size and forecast 2023-2028; Chart on Hospitals - Market size and forecast 2023-2028 ($ million); Data Table on Hospitals - Market size and forecast 2023-2028 ($ million); Chart on Hospitals - Year-over-year growth 2023-2028 (%); Data Table on Hospitals - Year-over-year growth 2023-2028 (%); 6.4 Dermatology clinics - Market size and forecast 2023-2028; Chart on Dermatology clinics - Market size and forecast 2023-2028 ($ million); Data Table on Dermatology clinics - Market size and forecast 2023-2028 ($ million); Chart on Dermatology clinics - Year-over-year growth 2023-2028 (%); Data Table on Dermatology clinics - Year-over-year growth 2023-2028 (%); 6.5 Pharmacies - Market size and forecast 2023-2028; Chart on Pharmacies - Market size and forecast 2023-2028 ($ million); Data Table on Pharmacies - Market size and forecast 2023-2028 ($ million); Chart on Pharmacies - Year-over-year growth 2023-2028 (%); Data Table on Pharmacies - Year-over-year growth 2023-2028 (%); 6.6 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 6.7 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type: 7.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 7.3 Prescription - Market size and forecast 2023-2028; Chart on Prescription - Market size and forecast 2023-2028 ($ million); Data Table on Prescription - Market size and forecast 2023-2028 ($ million); Chart on Prescription - Year-over-year growth 2023-2028 (%); Data Table on Prescription - Year-over-year growth 2023-2028 (%); 7.4 OTC - Market size and forecast 2023-2028; Chart on OTC - Market size and forecast 2023-2028 ($ million); Data Table on OTC - Market size and forecast 2023-2028 ($ million); Chart on OTC - Year-over-year growth 2023-2028 (%); Data Table on OTC - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Type; Market opportunity by Type ($ million); Data Table on Market opportunity by Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 Russia - Market size and forecast 2023-2028; Chart on Russia - Market size and forecast 2023-2028 ($ million); Data Table on Russia - Market size and forecast 2023-2028 ($ million); Chart on Russia - Year-over-year growth 2023-2028 (%); Data Table on Russia - Year-over-year growth 2023-2028 (%); 9.9 Saudi Arabia - Market size and forecast 2023-2028; Chart on Saudi Arabia - Market size and forecast 2023-2028 ($ million); Data Table on Saudi Arabia - Market size and forecast 2023-2028 ($ million); Chart on Saudi Arabia - Year-over-year growth 2023-2028 (%); Data Table on Saudi Arabia - Year-over-year growth 2023-2028 (%); 9.10 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.11 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; 12.4 Astellas Pharma Inc.; Astellas Pharma Inc. - Overview; Astellas Pharma Inc. - Product / Service; Astellas Pharma Inc. - Key news; Astellas Pharma Inc. - Key offerings; 12.5 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; 12.6 Bausch Health Companies Inc.; Bausch Health Companies Inc. - Overview; Bausch Health Companies Inc. - Business segments; Bausch Health Companies Inc. - Key news; Bausch Health Companies Inc. - Key offerings; Bausch Health Companies Inc. - Segment focus; 12.7 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; 12.8 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key news; Eli Lilly and Co. - Key offerings; 12.9 Galderma SA; Galderma SA - Overview; Galderma SA - Product / Service; Galderma SA - Key offerings; 12.10 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; 12.11 Glenmark Pharmaceuticals Ltd.; Glenmark Pharmaceuticals Ltd. - Overview; Glenmark Pharmaceuticals Ltd. - Product / Service; Glenmark Pharmaceuticals Ltd. - Key news; Glenmark Pharmaceuticals Ltd. - Key offerings; 12.12 LEO Pharma AS; LEO Pharma AS - Overview; LEO Pharma AS - Business segments; LEO Pharma AS - Key offerings; LEO Pharma AS - Segment focus; 12.13 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; 12.14 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; 12.15 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; 12.16 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; 12.17 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Topical Corticosteroids Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on End-user - Market share 2023-2028 (%); Exhibits33: Data Table on End-user - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by End-user; Exhibits35: Data Table on Comparison by End-user; Exhibits36: Chart on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Hospitals - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Dermatology clinics - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Dermatology clinics - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Dermatology clinics - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Dermatology clinics - Year-over-year growth 2023-2028 (%); Exhibits44: Chart on Pharmacies - Market size and forecast 2023-2028 ($ million); Exhibits45: Data Table on Pharmacies - Market size and forecast 2023-2028 ($ million); Exhibits46: Chart on Pharmacies - Year-over-year growth 2023-2028 (%); Exhibits47: Data Table on Pharmacies - Year-over-year growth 2023-2028 (%); Exhibits48: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits49: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits50: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits51: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits52: Market opportunity by End-user ($ million); Exhibits53: Data Table on Market opportunity by End-user ($ million); Exhibits54: Chart on Type - Market share 2023-2028 (%); Exhibits55: Data Table on Type - Market share 2023-2028 (%); Exhibits56: Chart on Comparison by Type; Exhibits57: Data Table on Comparison by Type; Exhibits58: Chart on Prescription - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Prescription - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Prescription - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Prescription - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on OTC - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on OTC - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on OTC - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on OTC - Year-over-year growth 2023-2028 (%); Exhibits66: Market opportunity by Type ($ million); Exhibits67: Data Table on Market opportunity by Type ($ million); Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits69: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits70: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits71: Chart on Geographic comparison; Exhibits72: Data Table on Geographic comparison; Exhibits73: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on Russia - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on Russia - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on Russia - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on Russia - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on Saudi Arabia - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on Saudi Arabia - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on Saudi Arabia - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on Saudi Arabia - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits109: Market opportunity By Geographical Landscape ($ million); Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits111: Impact of drivers and challenges in 2023 and 2028; Exhibits112: Overview on criticality of inputs and factors of differentiation; Exhibits113: Overview on factors of disruption; Exhibits114: Impact of key risks on business; Exhibits115: Companies covered; Exhibits116: Matrix on companies position and classification; Exhibits117: AbbVie Inc. - Overview; Exhibits118: AbbVie Inc. - Product / Service; Exhibits119: AbbVie Inc. - Key news; Exhibits120: AbbVie Inc. - Key offerings; Exhibits121: Astellas Pharma Inc. - Overview; Exhibits122: Astellas Pharma Inc. - Product / Service; Exhibits123: Astellas Pharma Inc. - Key news; Exhibits124: Astellas Pharma Inc. - Key offerings; Exhibits125: AstraZeneca Plc - Overview; Exhibits126: AstraZeneca Plc - Product / Service; Exhibits127: AstraZeneca Plc - Key news; Exhibits128: AstraZeneca Plc - Key offerings; Exhibits129: Bausch Health Companies Inc. - Overview; Exhibits130: Bausch Health Companies Inc. - Business segments; Exhibits131: Bausch Health Companies Inc. - Key news; Exhibits132: Bausch Health Companies Inc. - Key offerings; Exhibits133: Bausch Health Companies Inc. - Segment focus; Exhibits134: Bayer AG - Overview; Exhibits135: Bayer AG - Business segments; Exhibits136: Bayer AG - Key news; Exhibits137: Bayer AG - Key offerings; Exhibits138: Bayer AG - Segment focus; Exhibits139: Eli Lilly and Co. - Overview; Exhibits140: Eli Lilly and Co. - Product / Service; Exhibits141: Eli Lilly and Co. - Key news; Exhibits142: Eli Lilly and Co. - Key offerings; Exhibits143: Galderma SA - Overview; Exhibits144: Galderma SA - Product / Service; Exhibits145: Galderma SA - Key offerings; Exhibits146: GlaxoSmithKline Plc - Overview; Exhibits147: GlaxoSmithKline Plc - Business segments; Exhibits148: GlaxoSmithKline Plc - Key news; Exhibits149: GlaxoSmithKline Plc - Key offerings; Exhibits150: GlaxoSmithKline Plc - Segment focus; Exhibits151: Glenmark Pharmaceuticals Ltd. - Overview; Exhibits152: Glenmark Pharmaceuticals Ltd. - Product / Service; Exhibits153: Glenmark Pharmaceuticals Ltd. - Key news; Exhibits154: Glenmark Pharmaceuticals Ltd. - Key offerings; Exhibits155: LEO Pharma AS - Overview; Exhibits156: LEO Pharma AS - Business segments; Exhibits157: LEO Pharma AS - Key offerings; Exhibits158: LEO Pharma AS - Segment focus; Exhibits159: Merck and Co. Inc. - Overview; Exhibits160: Merck and Co. Inc. - Business segments; Exhibits161: Merck and Co. Inc. - Key news; Exhibits162: Merck and Co. Inc. - Key offerings; Exhibits163: Merck and Co. Inc. - Segment focus; Exhibits164: Novartis AG - Overview; Exhibits165: Novartis AG - Business segments; Exhibits166: Novartis AG - Key news; Exhibits167: Novartis AG - Key offerings; Exhibits168: Novartis AG - Segment focus; Exhibits169: Pfizer Inc. - Overview; Exhibits170: Pfizer Inc. - Product / Service; Exhibits171: Pfizer Inc. - Key news; Exhibits172: Pfizer Inc. - Key offerings; Exhibits173: Sanofi SA - Overview; Exhibits174: Sanofi SA - Business segments; Exhibits175: Sanofi SA - Key news; Exhibits176: Sanofi SA - Key offerings; Exhibits177: Sanofi SA - Segment focus; Exhibits178: Viatris Inc. - Overview; Exhibits179: Viatris Inc. - Business segments; Exhibits180: Viatris Inc. - Key news; Exhibits181: Viatris Inc. - Key offerings; Exhibits182: Viatris Inc. - Segment focus; Exhibits183: Inclusions checklist; Exhibits184: Exclusions checklist; Exhibits185: Currency conversion rates for US$; Exhibits186: Research methodology; Exhibits187: Information sources; Exhibits188: Data validation; Exhibits189: Validation techniques employed for market sizing; Exhibits190: Data synthesis; Exhibits191: 360 degree market analysis; Exhibits192: List of abbreviations

Pricing

Currency Rates

Single User Online Download $2,500
Global Site License Online Download $4,000

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now